Nursing-Driven Primary Palliative Care for Urban-Dwelling African Americans With Chronic Lung Disease
Hillman
2 other identifiers
interventional
23
1 country
1
Brief Summary
In prior work, this research team developed a telehealth primary care model (TIPC), designed in close partnership with patients and clinicians to address a widespread increase in telehealth use during the COVID-19 pandemic. Researchers will test the TIPC intervention to assess palliative care (PC) support for patients with chronic obstructive pulmonary disease (COPD) among a population of urban-dwelling, African American (AA) persons over the course of 15 months. The aims of this study are to 1) evaluate patient, caregiver, and clinical team perspectives of feasibility and acceptability of the TIPC model with urban-dwelling AAs with advanced COPD, and 2) explore the impact of TIPC intervention on knowledge and completion of advanced care planning (ACP) and on hospice and healthcare utilization patterns in the target population, as well as on additional quality of life (QOL) endpoints, and compare these between individuals participating in the intervention group and control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2022
CompletedFirst Posted
Study publicly available on registry
November 9, 2022
CompletedStudy Start
First participant enrolled
December 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedFebruary 6, 2024
February 1, 2024
12 months
September 27, 2022
February 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Feasibility, Acceptability, Satisfaction regarding TIPC intervention as Assessed by Survey
Participants in the intervention group will report their experience with the TIPC model via survey questions. Participants will indicate whether or not they strongly disagree, disagree, have no opinion, agree, or strongly agree with a series of statements asking them about their experience with TIPC intervention.
6 months
Secondary Outcomes (11)
Change in Knowledge of Advanced Care Planning (ACP)
3 months
Change in Knowledge of Advanced Care Planning (ACP)
6 months
Change in Disease-Specific Quality of Life as Assessed by the CCQ
Baseline
Change in Disease-Specific Quality of Life as Assessed by the CCQ
3 months
Change in Disease-Specific Quality of Life as Assessed by the CCQ
6 months
- +6 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALIndividuals in the intervention group will undergo a series of two telehealth video visits and a series of survey assessments at baseline, 3, and 6 months.
Control
NO INTERVENTIONIndividuals in the control group will continue with their usual standard of care and undergo a series of survey assessments at baseline, 3, and 6 months.
Interventions
The TIPC model of intervention incorporates video visits across research clinicians and patients' existing care clinicians for more synergized and accessible care provision for a given clinical indication. The first TIPC visit will center around the patient setting care goals for themselves and their caregiver with the help of a palliative care physician. The second TIPC visit will focus on assessing goal attainment and also close the care loop between their existing care team, a research-appointed palliative care team, and their involvement in our study.
Eligibility Criteria
You may qualify if:
- COPD Diagnosis
- Age 18 years or older
You may not qualify if:
- Traumatic Brain Injuries
- Incarceration
- Homelessness
- Developmental disorders
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Thomas Jefferson Universitylead
- Rita & Alex Hillman Foundationcollaborator
Study Sites (1)
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-Principal Investigator
Study Record Dates
First Submitted
September 27, 2022
First Posted
November 9, 2022
Study Start
December 2, 2022
Primary Completion
November 30, 2023
Study Completion
November 30, 2023
Last Updated
February 6, 2024
Record last verified: 2024-02